Sarah Krüg
President, Society for Participatory Medicine & CEO, CANCER101

About Me

Sarah Krüg, CEO of CANCER101, a patient advocacy organization. She has been on the board for three years, in a quest to help patients and caregivers navigate the cancer journey. She is also President of the Society for Participatory Medicine, a patient/provider member driven organization whose mission is to enable collaborative partnerships between patients and healthcare professionals. She serves on the board of the Cancer Patient Education Network, an organization created by NCI over 25 years ago to provide a framework for patient educators across institutions worldwide. She also serves on the board of the National Organization of Rare Diseases.

She previously held the position of Global Education Director in the Medical Education Group at Pfizer, focused on establishing global health care improvement strategies and medical education standards worldwide. She also established the Global Investigator Initiated Research Program at Pfizer.  Prior to joining Pfizer, Sarah spearheaded the development of the Pediatric Disease Management clinical pathways and conducted clinical research at Memorial Sloan- Kettering Cancer Center.

In her spare time, Sarah enjoys writing and is contributing writer for Pharmaceutical Executive. She is also in the midst of completing two books.


At Medicine X 2015

Saturday, September 28 12:20 pm (LK 120)
Participatory medicine: a catalyst in reducing medical errors
“To err is human, to cover up is unforgivable, and to fail to learn is inexcusable.”  – Sir Liam Donaldson Medical errors or adverse events happen when there is a misstep in a chain of activities... Read more
Sunday, September 29 8:10 am (Plenary Hall)
Update from SPM
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search